(1R,9S)-11-(2-Hydroxybenzyl)-5-[4-(methylsulfanyl)phenyl]-7,11-diazatricyclo[7.3.1.0^2,7]trideca-2,4-dien-6-one

ID: Reference9731

C₂₅H₂₆N₂O₂S

(1R,9S)-11-[(2-Hydroxyphenyl)methyl]-5-(4-methylsulfanylphenyl)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one; 1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-3-[(2-hydroxyphenyl)methyl]-9-[4-(methylthio)phenyl]-, (1R,5S)-; NAT11-286927

Thromboxane B3

ID: Reference9756

C₂₀H₃₂O₆

(5E,13E,17E)-9,11,15-Trihydroxythromboxa-5,13,17-trien-1-oic acid; (5E)-7-{4,6-Dihydroxy-2-[(1E,5E)-3-hydroxyocta-1,5-dien-1-yl]oxan-3-yl}hept-5-enoic acid; (5Z,9a,13E,15S,17Z)-9,11,15-Trihydroxy-thromboxa-5,13,17-trien-1-oate; (5Z,9a,13E,15S,17Z)-9,11,15-Trihydroxy-thromboxa-5,13,17-trien-1-oic acid; [2R(1E,3S,5Z),3S(Z),4S]-[Partial]-7-[tetrahydro-4,6-dihydroxy-2-(3-hydroxy-1,5-octadienyl)-2H-pyran-3-yl]-5-heptenoate; [2R(1E,3S,5Z),3S(Z),4S]-[Partial]-7-[tetrahydro-4,6-dihydroxy-2-(3-hydroxy-1,5-octadienyl)-2H-pyran-3-yl]-5-heptenoic acid; 9S,11,15S-Trihydroxy-thromboxa-5Z,13E,17Z-trien-1-oate

Estriol

ID: Reference9771

C₁₈H₂₄O₃

(16α,17β)-Estra-1(10),2,4-triene-3,16,17-triol; (16α,17β)-Estra-1,3,5(10)-triene-3,16,17-triol; (16α,17β)-Oestra-1,3,5(10)-triene-3,16,17-triol; 1,3,5(10)-Estratriene-3,16,17-triol; 1,3,5(10)-Estratriene-3,16-α,17β-triol; 1,3,5-Estratriene-3β,16α,17β-triol; 1,3,5-Oestratriene-3β,16α,17β-triol

19(R)-Hydroxy prostaglandin F2α

ID: Reference9779

C₂₀H₃₄O₆

(5Z,9α,11α,13E,15S,19R)-9,11,15,19-Tetrahydroxyprosta-5,13-dien-1-oic acid; 19(R)-Hydroxy prostaglandin F2α; 19R-19-Hydroxy PGF-2α; 19R-Hydroxy-PGF2α; 9S,11R,15S,19R-Tetrahydroxy-5Z,13E-prostadienoic acid

20-Hydroxy prostaglandin F2α

ID: Reference9822

C₂₀H₃₄O₆

(5Z,9α,11α,13E,15S)-9,11,15,20-Tetrahydroxyprosta-5,13-dien-1-oic acid; 20-Hydroxy-pgf2a; 9S,11S,15S,20-Tetrahydroxy-5Z,13E-prostadienoate

Tauroursodeoxycholic acid

ID: Reference9838

C₂₆H₄₅NO₆S

2-{[(3α,5β,7β)-3,7-Dihydroxy-24-oxocholan-24-yl]amino}ethanesulfonic acid; TUDA; TUDCA; N-Ursodeoxycholoyltaurine; Sodium tauroursodeoxycholate; Taurolite; Tauroursodeoxycholate

Glycochenodeoxycholic acid

ID: Reference9839

C₂₆H₄₃NO₅

N-[(3α,5β,7α)-3,7-Dihydroxy-24-oxocholan-24-yl]glycine; GCDA; GCDCA; Chenodeoxycholylglycine; Chenodeoxyglycocholate; Chenodeoxyglycocholic acid; Glycine chenodeoxycholate

8,12-iso-iPF2α-VI-1,5-lactone

ID: Reference9845

C₂₀H₃₂O₄

(6E,9α,11α,12α,14Z)-9,11-Dihydroxy-1,5-epoxyprosta-6,14-dien-1-one; 6-((E)-2-((1R,2S,3R,5S)-3,5-Dihydroxy-2-((Z)-oct-2-enyl)cyclopentyl)vinyl)tetrahydro-2H-pyran-2-one

Docosahexaenoyl ethanolamide

ID: Reference9860

C₂₄H₃₇NO₂

(4Z,7Z,10Z,13Z,16Z,19Z)-N-(2-Hydroxyethyl)-4,7,10,13,16,19-docosahexaenamide; DHEA; N-(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoylethanolamine; N-cis-4,7,10,13,16,19-Docosahexanoylethanolamine; (4Z,7Z,10Z,13Z,16Z,19Z)-N-(2-Hydroxyethyl)docosa-4,7,10,13,16,19-hexaenamide; 4,7,10,13,16,19-Docosahexaenamide, N-(2-hydroxyethyl)-, (4Z,7Z,10Z,13Z,16Z,19Z)-; Anandamide (22:6, N-3)

Bicyclo prostaglandin E2

ID: Reference9862

C₂₀H₃₀O₄

(Z)-7-[(1R,3aS,7aS)-4-Butyl-2,5-dioxo-3,3a,4,6,7,7a-hexahydro-1H-inden-1-yl]hept-5-enoic acid; (5Z,11β)-9,15-Dioxo-11,16-cycloprost-5-en-1-oic acid; 11-Deoxy-13,14-dihydro-15-keto-11β,16χ-cycloprostaglandin E2; 9,15-Dioxo-5Z-prostaenoic acid-cyclo[11S,16]; 5-Heptenoic acid,7-[(1R,3as,7as)-4-butyloctahydro-2,5-dioxo-1H-inden-1-yl]-,(5Z)-; Bicyclo PGE₂

19(R)-Hydroxy prostaglandin F1α

ID: Reference9866

C₂₀H₃₆O₆

(9α,11α,13E,15S,19R)-9,11,15,19-Tetrahydroxyprost-13-en-1-oic acid; 19(R)-Hydroxy prostaglandin F1α; 19R-Hydroxy-PGF1α; Prost-13-en-1-oic acid,9,11,15,19-tetrahydroxy-,(9a,11a,13E,15S,19R)-(9ci)

15(R),19(R)-Hydroxy prostaglandin F2α

ID: Reference9868

C₂₀H₃₄O₆

(5Z,9α,11α,13E,15R,19R)-9,11,15,19-Tetrahydroxyprosta-5,13-dien-1-oic acid; 9α,11α,15R,19R-Tetrahydroxy-prosta-5Z,13E-dien-1-oic acid; 15(R),19(R)-hydroxy PGF_2α